osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

  1. Nathan Bucay,
  2. Ildiko Sarosi,
  3. Colin R. Dunstan,
  4. Sean Morony,
  5. John Tarpley,
  6. Casey Capparelli,
  7. Sheila Scully,
  8. Hong Lin Tan,
  9. Weilong Xu,
  10. David L. Lacey,
  11. William J. Boyle, and
  12. W. Scott Simonet
  1. Departments of Molecular Genetics, Pathology, and Cell Biology, Amgen, Inc., Thousand Oaks, California 91320-1789 USA

Abstract

Osteoprotegerin (OPG) is a secreted protein that inhibits osteoclast formation. In this study the physiological role of OPG is investigated by generating OPG-deficient mice. Adolescent and adult OPG −/− mice exhibit a decrease in total bone density characterized by severe trabecular and cortical bone porosity, marked thinning of the parietal bones of the skull, and a high incidence of fractures. These findings demonstrate that OPG is a critical regulator of postnatal bone mass. Unexpectedly,OPG-deficient mice also exhibit medial calcification of the aorta and renal arteries, suggesting that regulation of OPG, its signaling pathway, or its ligand(s) may play a role in the long observed association between osteoporosis and vascular calcification.

Keywords

Footnotes

  • Corresponding author.

  • E-MAIL ssimonet{at}amgen.com; FAX (805) 447-1982.

    • Received February 9, 1998.
    • Accepted March 19, 1998.
| Table of Contents

Life Science Alliance